Principal Investigator
Hagar Dewidar, Instructor
Tanta University
Total Trials
1
As PI
1
Completed
1
h-index
N/A
Publications
0
Years Active
0
Research Impact
h-index
N/A
Research impact score
Publications
0
Total publications
Trial Results
0
Published trial results
Citations
0
Total citations
Drug Portfolio
MIXED(2)
DRUG(1)
Doxorubicin
1 trial
phase_2
tanta-universityCyclophosphamide
1 trial
phase_2
tanta-universityFenofibrate
1 trial
phase_2
tanta-university3 unique interventions2 categories
Analytics
Trial Phases
Phase 21
Trial Status
Completed1
Role Distribution
Principal Investigator1
PI Rate100%
Activity Timeline
Clinical Trials (1)
Evaluation of Possible Safety and Efficacy of Fenofibrate in the Prophylaxis of Doxorubicin Induced Cardiotoxicity in Breast Cancer Patients
Breast Cancer Stage 2 and 3
PrincipalinvestigatorStart date: 2023-12-01
Research Network
Collaboration Network
1 collaborators·0 connections
Network Legend
KOL
Current InvestigatorCO
High-influence CollaboratorCO
CollaboratorClick: view details
Double-click: go to profile
Drag: move node
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Tanta University
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Similar investigators will appear here based on research areas and collaboration patterns.
Publications (0)
No publications found for this investigator.
Clinical Trials (1)
Showing 1 of 1 trials
Evaluation of Possible Safety and Efficacy of Fenofibrate in the Prophylaxis of Doxorubicin Induced Cardiotoxicity in Breast Cancer Patients
Breast Cancer Stage 2 and 3
All 1 trials loaded